In this study, we investigated whether or not serum HO-1, which reflects the degree of oxidative stress in COVID-19 patients, could be a useful biomarker in predicting disease severity and determining a prognosis by making a comparison to those of sCD163. This evidence concerns the gene CD163 and COVID-19.